Home > News > Intel charts new seas
November 21st, 2003
Intel charts new seas
Abstract:
For the first time, Intel Corp. has made available its chip-making nanotechnology tools to cancer researchers in the hope that being able to detect tiny defects in silicon chips also will work in human tissue to diagnose and study cancer. Though just preliminary research, Intel's union with the Fred Hutchinson Cancer Research Center in Seattle is part of a voyage toward its future beyond pure-silicon manufacturing. After all, Intel's advanced chips will be commodities within several years, say experts.
Source:
SVBI
Related News Press |
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||